HA35 Moderate Alcoholic Hepatitis (AH) Study

NCT05018481 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Alcoholic Hepatitis

Interventions

DRUG: Sodium Hyaluronate
DRUG: Placebo

Sponsor

The Cleveland Clinic